Test Price
2,800 AED✅ Home Collection Available
TERT Gene Dyskeratosis Congenita Genetic Test in UAE | 2800 AED | DHA Certified
Executive Summary & Core Metrics
Executive Summary
DHA-compliant TERT gene sequencing with 99.9% diagnostic sensitivity, ISO-certified home collection (cold-chain), and post-test clinical guidance.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TERT gene test analyzes the telomerase reverse transcriptase gene for mutations causing Dyskeratosis Congenita (autosomal recessive type 4 / autosomal dominant type 2). This test aids dermatologists, oncologists, and clinical geneticists in diagnosing telomere biology disorders, guiding cancer surveillance and family planning.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with high coverage and CNV analysis | Targeted Sanger sequencing (limited to known exons) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Yield | >95% for TERT mutations | ~85% |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) emphasizes: “This TERT gene sequencing test provides a definitive molecular diagnosis for Dyskeratosis Congenita, enabling early intervention and tailored cancer surveillance. Interpretation must be integrated with clinical findings and family history. Our team supports clinicians through every step, ensuring clarity and precision.”
Medication Advisory
Maintain all current medications unless otherwise instructed by your prescribing doctor. The TERT gene test does not interfere with pharmaceutical regimens; however, certain drugs like androgens or growth factors may influence bone marrow parameters. Always provide a complete medication list to the genetic counselor before testing.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent blood transfusion or allogeneic stem cell transplant (within 3 months) may cause donor DNA interference; patients unable to provide informed consent; minors require parental/guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: Seek immediate medical attention if you experience sudden severe bruising, unexplained bleeding, or signs of bone marrow failure (e.g., extreme fatigue, recurrent infections) during the testing period.
Patient FAQ & Clinical Guidance
1. What does the TERT gene test detect in Dyskeratosis Congenita?
The TERT gene test detects inherited mutations in the telomerase reverse transcriptase gene that cause Dyskeratosis Congenita, a telomere biology disorder leading to bone marrow failure, skin abnormalities, and increased cancer risk. This high-sensitivity NGS assay identifies point mutations, small insertions/deletions, and copy number variations, providing conclusive molecular diagnosis for autosomal recessive type 4 and autosomal dominant type 2. Early detection enables life‑saving surveillance for myelodysplasia, leukemia, and solid tumors. Results should be discussed with a clinical geneticist.
2. How should I prepare for the TERT gene test and what sample is required?
A simple blood draw, one drop of blood on an FTA card, or previously extracted DNA is accepted; fasting for 8–12 hours is advised only if a concurrent metabolic panel is ordered, and a genetic counselling session is recommended to map your family pedigree. Home collection by VIP phlebotomists ensures strict cold‑chain transport, maintaining DNA integrity. For minors, Federal Decree-Law No. 4 of 2016 mandates parental consent and the presence of a guardian during collection. Results are ready in 3–4 weeks with a telephonic consultation to explain findings.
3. Is the TERT genetic test covered by UAE insurance and what is the cost?
The costs 2800 AED, and we offer direct billing verification via WhatsApp at +971 54 548 8731; most UAE insurers cover genetic testing for suspected Dyskeratosis Congenita when preauthorized under DHA guidelines. Our team assists with ICD‑10 coding (Q82.8, D61.09) and provides a detailed medical report to support claims. For self‑pay patients, the price is transparent with no hidden fees, and all transactions comply with UAE PDPL for genetic data privacy.
UAE Regulatory & Data Privacy Adherence
- DHA Facility License: 1143
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) for consistent laboratory quality.
- Strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Results reviewed by DHA-licensed Consultant Medical Genetics (Lina Osama Zaki Quteineh, DHA 9294403) with 15+ years of molecular diagnostics expertise.
Clinical & Logistical Metadata
| Test Name | TERT Gene Sequencing (Dyskeratosis Congenita) |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), FTA card, or extracted DNA via VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | Q82.8, D61.09 |
| LOINC Code | 48018-6 |
| DHA Facility License & Address | Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians